Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Gross Margin
Nichi-Iko Pharmaceutical Co Ltd
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
| Country | JP |
| Market Cap | 776 550.9T JPY |
| Gross Margin |
-3%
|
| Country | US |
| Market Cap | 733.9B USD |
| Gross Margin |
80%
|
| Country | DK |
| Market Cap | 4.1T DKK |
| Gross Margin |
85%
|
| Country | UK |
| Market Cap | 440.4B GBP |
| Gross Margin |
56%
|
| Country | US |
| Market Cap | 370.3B USD |
| Gross Margin |
70%
|
| Country | US |
| Market Cap | 331.5B USD |
| Gross Margin |
75%
|
| Country | UK |
| Market Cap | 188.6B GBP |
| Gross Margin |
82%
|
| Country | CH |
| Market Cap | 187.2B CHF |
| Gross Margin |
73%
|
| Country | CH |
| Market Cap | 181.1B CHF |
| Gross Margin |
74%
|
| Country | US |
| Market Cap | 163.3B USD |
| Gross Margin |
70%
|
| Country | FR |
| Market Cap | 113.2B EUR |
| Gross Margin |
69%
|
Profitability Report
View the profitability report to see the full profitability analysis for Nichi-Iko Pharmaceutical Co Ltd.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Nichi-Iko Pharmaceutical Co Ltd's most recent financial statements, the company has Gross Margin of -2.6%.
You don't have any saved screeners yet
